5AM Venture Management as of Sept. 30, 2023
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 26 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Enliven Therapeutics (ELVN) | 20.3 | $71M | 5.2M | 13.66 | |
| Entrada Therapeutics (TRDA) | 20.0 | $70M | 4.4M | 15.80 | |
| Disc Medicine (IRON) | 5.9 | $21M | 438k | 46.98 | |
| Dianthus Therapeutics (DNTH) | 5.8 | $20M | 1.5M | 13.67 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 5.1 | $18M | 313k | 57.00 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.0 | $14M | 462k | 29.74 | |
| Vor Biopharma (VOR) | 3.9 | $14M | 6.4M | 2.12 | |
| Pharvaris N V (PHVS) | 3.5 | $12M | 588k | 20.87 | |
| Rallybio Corp (RLYB) | 3.5 | $12M | 3.6M | 3.37 | |
| Zentalis Pharmaceuticals (ZNTL) | 2.8 | $9.8M | 490k | 20.06 | |
| Scpharmaceuticals (SCPH) | 2.5 | $8.5M | 1.2M | 7.12 | |
| Celldex Therapeutics Com New (CLDX) | 2.5 | $8.5M | 310k | 27.52 | |
| Mirati Therapeutics | 2.4 | $8.4M | 193k | 43.56 | |
| Cogent Biosciences (COGT) | 2.2 | $7.7M | 790k | 9.75 | |
| Viking Therapeutics (VKTX) | 1.9 | $6.5M | 585k | 11.07 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $6.4M | 358k | 17.96 | |
| Miragen Therapeutics (VRDN) | 1.8 | $6.3M | 410k | 15.34 | |
| Arvinas Ord (ARVN) | 1.8 | $6.3M | 320k | 19.64 | |
| Tyra Biosciences (TYRA) | 1.6 | $5.7M | 412k | 13.77 | |
| Spruce Biosciences (SPRB) | 1.5 | $5.3M | 2.4M | 2.26 | |
| Homology Medicines | 1.5 | $5.3M | 4.5M | 1.17 | |
| Avidity Biosciences Ord (RNA) | 1.2 | $4.2M | 666k | 6.38 | |
| Gh Research Ordinary Shares (GHRS) | 1.2 | $4.1M | 404k | 10.05 | |
| Mersana Therapeutics (MRSN) | 0.5 | $1.7M | 1.3M | 1.27 | |
| Impel Neuropharma (IMPLQ) | 0.4 | $1.2M | 2.9M | 0.43 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.3 | $1.1M | 1.1M | 0.94 |
